February 12, 2019
Distinguished Dana-Farber Cancer Institute Physician and Harvard Medical School Professor joins new open-innovation, immuno-oncology joint venture between HiFiBiO Therapeutics and Vikas P. Sukhatme CAMBRIDGE, Mass. – February 12, 2019 – HiFiBiO Therapeutics, a world leader in the discovery and development of therapeutic antibodies enabled by unique single-cell profiling and full immune repertoire screening, today announced...
Read More